Estimated reading time: 1 minutes
Many clinical trials of new cancer drugs may be inappropriately excluding some people with Duffy-null phenotype, a trait found predominantly in people of African or Middle Eastern descent, researchers report in a new study.
About The Author
Discover more from Life is Pro-Mazing!
Subscribe to get the latest posts sent to your email.